Articles
29.01.2019
Voluntary scheme for branded medicines pricing

Overall, the 2019 Voluntary Scheme has taken significant measures to reduce the time taken for patie...

Read more
Articles
18.01.2019
Game changing drug launches to watch

13 market-changing drugs are expected to hit the European market this year and these blockbusters re...

Read more
Articles
12.12.2018
Medicare drug pricing

Medicare would use a new International Pricing Index (IPI) model that considers international refere...

Read more
Articles
03.12.2018
NICE META tool assisting patient access

NICE has recently developed the META tool, to support MedTech manufacturers in the identification of...

Read more
Articles
24.10.2018
Patient access to high-cost orphan drugs

Orphan drugs have important societal value as they improve patient quality of life and address unmet...

Read more
Articles
11.09.2018
NICE providing access to CAR-T therapy

Earlier this year, the UK government announced support for three new specialist centres capable of c...

Read more
Articles
29.08.2018
Brexit pharmaceutical market access and the UK

With eight months left before the UK leaves the EU in March 2019, it was hoped that a clear strategy...

Read more
Articles
24.08.2018
Treatment for rare conditions

Faster access to new treatments for very rare conditions announced following a revised decision maki...

Read more
Articles
17.08.2018
Biosimilars Price Controls

The government has launched a consultation that outlines the proposed changes to its price controls ...

Read more
Articles
25.07.2018
EU-wide HTA clinical assessment

The European Commission (EC) has recently set out its draft proposal for adopting an EU-wide health...

Read more

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.